Letrozole 2.5 mg tablets are a generic formulation (YJ code: 4291015F1018, standard: 2.5 mg 1 tablet) containing letrozole, an aromatase inhibitor used to treat hormone receptor-positive breast cancer in postmenopausal women.
Letrozole 2.5 mg tablets
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
